These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19035465)
1. A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells. Yi ZF; Cho SG; Zhao H; Wu YY; Luo J; Li D; Yi T; Xu X; Wu Z; Liu M Int J Cancer; 2009 Feb; 124(4):843-52. PubMed ID: 19035465 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
4. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway. Wu Y; He L; Zhang L; Chen J; Yi Z; Zhang J; Liu M; Pang X J Pharmacol Exp Ther; 2011 Nov; 339(2):403-11. PubMed ID: 21828260 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a). Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999 [TBL] [Abstract][Full Text] [Related]
6. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling. Liu Y; He Y; Yang F; Cong X; Wang J; Peng S; Gao D; Wang W; Lan L; Ying X; Liu M; Chen Y; Yi Z Sci China Life Sci; 2017 Feb; 60(2):202-214. PubMed ID: 28194552 [TBL] [Abstract][Full Text] [Related]
7. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo. Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024 [TBL] [Abstract][Full Text] [Related]
8. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways. Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218 [TBL] [Abstract][Full Text] [Related]
9. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Pang X; Yi T; Yi Z; Cho SG; Qu W; Pinkaew D; Fujise K; Liu M Cancer Res; 2009 Jan; 69(2):518-25. PubMed ID: 19147565 [TBL] [Abstract][Full Text] [Related]
10. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450 [TBL] [Abstract][Full Text] [Related]
11. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers. Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V. Wang Z; Zhao H; Ma JX; Xu X Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210 [TBL] [Abstract][Full Text] [Related]
13. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway. Jung MH; Lee SH; Ahn EM; Lee YM Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Soto-Pantoja DR; Menon J; Gallagher PE; Tallant EA Mol Cancer Ther; 2009 Jun; 8(6):1676-83. PubMed ID: 19509262 [TBL] [Abstract][Full Text] [Related]
15. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect. Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043 [TBL] [Abstract][Full Text] [Related]
16. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling. Huang SW; Lien JC; Kuo SC; Huang TF Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319 [TBL] [Abstract][Full Text] [Related]
17. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419 [TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling. De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149 [TBL] [Abstract][Full Text] [Related]
19. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
20. A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis. Bhattacharjee PS; Huq TS; Mandal TK; Graves RA; Muniruzzaman S; Clement C; McFerrin HE; Hill JM PLoS One; 2011 Jan; 6(1):e15905. PubMed ID: 21253017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]